Drugmakers Sue HHS To Curtail Discounts To Pharmacies
Law360 (January 13, 2021, 7:53 PM EST) -- AstraZeneca, Eli Lilly and Sanofi-Aventis have launched a series of lawsuits challenging the U.S. Department of Health and Human Services' view that drugmakers have to give discounts to pharmacies contracting with hospitals that participate in a program serving low-income areas.
On Tuesday, AstraZeneca Pharmaceuticals LP, Eli Lilly and Co. and Lilly USA LLC, and Sanofi-Aventis U.S. LLC launched federal lawsuits against HHS in Delaware, Indiana and New Jersey, respectively. The suits challenged a late-December advisory opinion in which HHS said that any pharmacy contracting with so-called 340B hospitals can get the same drug discounts those hospitals get.
The three suits said...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!